Published in Infect Agent Cancer on February 11, 2010
Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res (2012) 1.76
Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol (2012) 1.45
Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep (2014) 1.00
Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Arch (2010) 0.92
Human papillomavirus genotype and oropharynx cancer survival in the United States of America. Eur J Cancer (2015) 0.90
Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma. Cancer Clin Oncol (2013) 0.87
A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens. Open Virol J (2012) 0.81
Increased p16 DNA methylation in mouse thymic lymphoma induced by irradiation. PLoS One (2014) 0.80
p16 (INK4a) has clinicopathological and prognostic impact on oropharynx and larynx squamous cell carcinoma. Braz J Med Biol Res (2012) 0.77
p16 immunostaining as a predictor of anal and cervical dysplasia in women attending a sexually transmitted infection clinic. Indian J Sex Transm Dis (2016) 0.75
Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers. Cancer Med (2017) 0.75
Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas. Sci Rep (2016) 0.75
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst (2008) 8.70
The RB and p53 pathways in cancer. Cancer Cell (2002) 8.02
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol (2006) 5.86
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46
Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med (1995) 5.10
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst (2004) 3.43
Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer (2007) 2.75
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer (2003) 2.69
Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst (2007) 2.68
Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol (2003) 2.26
A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer (2003) 2.24
Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer (2003) 1.68
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res (1998) 1.63
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res (1996) 1.44
Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res (1999) 1.39
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res (2006) 1.37
Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck (2002) 1.32
P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol (2007) 1.30
P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol (2009) 1.29
The role of TP53 in Cervical carcinogenesis. Hum Mutat (2003) 1.23
p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res (2002) 1.14
Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene (1997) 1.01
Association between p53 and human papillomavirus in head and neck cancer survival. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst (2004) 3.43
Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res (2007) 2.93
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer (2003) 2.69
Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer (2004) 2.59
Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J (2007) 1.88
Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex Transm Dis (2004) 1.80
Competency assessment of residents in surgical pathology using virtual microscopy. Hum Pathol (2009) 1.54
Ultrasound-guided needle localization of recurrent paratracheal thyroid cancer. Ann Otol Rhinol Laryngol (2009) 1.43
Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer (2007) 1.39
P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol (2007) 1.30
Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control (2010) 1.30
Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion--absence of subset-specific glucocorticoid-induced immune cell loss. Alcohol Clin Exp Res (2007) 1.29
Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol (2012) 1.27
Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc (2003) (2004) 1.22
Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev (2005) 1.13
Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer (2010) 1.12
Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes. Virology (2002) 1.03
Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infect Agent Cancer (2011) 1.01
Evidence for vertical transmission of HPV from mothers to infants. Infect Dis Obstet Gynecol (2010) 1.00
The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J Virol (2008) 0.99
Linking clinical variables to health-related quality of life in Parkinson's disease. Parkinsonism Relat Disord (2002) 0.98
Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers? Cancer Epidemiol Biomarkers Prev (2008) 0.96
An exercise program to improve fall-related outcomes in elderly nursing home residents. Appl Nurs Res (2004) 0.95
Siblings' coping strategies and mental health services: a national study of siblings of persons with schizophrenia. Psychiatr Serv (2008) 0.95
Effects of a semioccluded vocal tract on laryngeal muscle activity and glottal adduction in a single female subject. Folia Phoniatr Logop (2008) 0.91
Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs. J Virol (2009) 0.90
Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol (2006) 0.89
Prevalence and persistence of human papillomavirus in postmenopausal age women. Cancer Detect Prev (2003) 0.88
Association between p53 and human papillomavirus in head and neck cancer survival. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras. Virology (2006) 0.87
Functional mapping of the human papillomavirus type 16 E1 cistron. J Virol (2008) 0.86
Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes. Virology (2010) 0.83
Laryngeal muscle activity in giggle: a damped oscillation model. J Voice (2007) 0.83
Infection of true vocal fold cyst with Aspergillus. Otolaryngol Head Neck Surg (2006) 0.83
Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. Carcinogenesis (2009) 0.81
Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation site. J Gen Virol (2009) 0.81
Analyzing the Human Papillomavirus (HPV) Life Cycle in Primary Keratinocytes with a Quantitative Colony-Forming Assay. Curr Protoc Microbiol (2014) 0.79
Preparedness for natural disasters among older US adults: a nationwide survey. Am J Public Health (2014) 0.78
Laryngeal trauma during awake fiberoptic intubation. Anesth Analg (2002) 0.77
Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation. Virology (2009) 0.77
In reference to Cost-effective dental protection during rigid endoscopy. Laryngoscope (2012) 0.75
A Web-based database for pathology faculty effort reporting. Hum Pathol (2008) 0.75
Radiology quiz case 1. Iodine 131–induced sialadenitis. Arch Otolaryngol Head Neck Surg (2012) 0.75